Global and United States Insomnia Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2015-2026)
2.2 Global Insomnia Therapy Growth Trends by Regions
2.2.1 Insomnia Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Insomnia Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Market Size
3.1.1 Global Top Insomnia Therapy Players by Revenue (2015-2020)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2019
3.5 Key Players Insomnia Therapy Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type (2015-2026)
4.1 Global Insomnia Therapy Historic Market Size by Type (2015-2020)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2021-2026)
5 Insomnia Therapy Breakdown Data by Application (2015-2026)
5.1 Global Insomnia Therapy Historic Market Size by Application (2015-2020)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Insomnia Therapy Market Size (2015-2026)
6.2 North America Insomnia Therapy Market Size by Type (2015-2020)
6.3 North America Insomnia Therapy Market Size by Application (2015-2020)
6.4 North America Insomnia Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2015-2026)
7.2 Europe Insomnia Therapy Market Size by Type (2015-2020)
7.3 Europe Insomnia Therapy Market Size by Application (2015-2020)
7.4 Europe Insomnia Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Insomnia Therapy Market Size (2015-2026)
8.2 China Insomnia Therapy Market Size by Type (2015-2020)
8.3 China Insomnia Therapy Market Size by Application (2015-2020)
8.4 China Insomnia Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Insomnia Therapy Market Size (2015-2026)
9.2 Japan Insomnia Therapy Market Size by Type (2015-2020)
9.3 Japan Insomnia Therapy Market Size by Application (2015-2020)
9.4 Japan Insomnia Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Insomnia Therapy Market Size (2015-2026)
10.2 Southeast Asia Insomnia Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Insomnia Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Insomnia Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2015-2020))
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2015-2020)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2015-2020)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
10.11.1 Fidia Farmaceutici Company Details
10.11.2 Fidia Farmaceutici Business Overview
10.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
10.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020)
10.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
10.12.1 Dainippon Sumitomo Company Details
10.12.2 Dainippon Sumitomo Business Overview
10.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
10.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020)
10.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
10.13.1 Biocodex Company Details
10.13.2 Biocodex Business Overview
10.13.3 Biocodex Insomnia Therapy Introduction
10.13.4 Biocodex Revenue in Insomnia Therapy Business (2015-2020)
10.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
10.14.1 Eli Lilly and Company Company Details
10.14.2 Eli Lilly and Company Business Overview
10.14.3 Eli Lilly and Company Insomnia Therapy Introduction
10.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020)
10.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
10.15.1 Ebb Therapeutics Company Details
10.15.2 Ebb Therapeutics Business Overview
10.15.3 Ebb Therapeutics Insomnia Therapy Introduction
10.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
10.15.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Non-pharmacological Therapy
Table 4. Key Players of Pharmacological Therapy
Table 5. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Insomnia Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Insomnia Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Insomnia Therapy Market Share by Regions (2015-2020)
Table 9. Global Insomnia Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Insomnia Therapy Market Share by Regions (2021-2026)
Table 11. Insomnia Therapy Market Market Trends
Table 12. Insomnia Therapy Market Drivers
Table 13. Insomnia Therapy Market Challenges
Table 14. Insomnia Therapy Market Restraints
Table 15. Global Insomnia Therapy Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Insomnia Therapy Market Share by Players (2015-2020)
Table 17. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019)
Table 18. Global Insomnia Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Therapy Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Insomnia Therapy Market Size Share by Type (2015-2020)
Table 24. Global Insomnia Therapy Revenue Market Share by Type (2021-2026)
Table 25. Global Insomnia Therapy Market Size Share by Application (2015-2020)
Table 26. Global Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Insomnia Therapy Market Size Share by Application (2021-2026)
Table 28. North America Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Insomnia Therapy Market Share by Type (2015-2020)
Table 30. North America Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Insomnia Therapy Market Share by Application (2015-2020)
Table 32. North America Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Insomnia Therapy Market Share by Country (2015-2020)
Table 34. Europe Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Insomnia Therapy Market Share by Type (2015-2020)
Table 36. Europe Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Insomnia Therapy Market Share by Application (2015-2020)
Table 38. Europe Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Insomnia Therapy Market Share by Country (2015-2020)
Table 40. China Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 41. China Insomnia Therapy Market Share by Type (2015-2020)
Table 42. China Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 43. China Insomnia Therapy Market Share by Application (2015-2020)
Table 44. China Insomnia Therapy Market Size by Region (US$ Million) (2015-2020)
Table 45. China Insomnia Therapy Market Share by Region (2015-2020)
Table 46. Japan Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Insomnia Therapy Market Share by Type (2015-2020)
Table 48. Japan Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Insomnia Therapy Market Share by Application (2015-2020)
Table 50. Japan Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Insomnia Therapy Market Share by Country (2015-2020)
Table 52. Southeast Asia Insomnia Therapy Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Insomnia Therapy Market Share by Type (2015-2020)
Table 54. Southeast Asia Insomnia Therapy Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Insomnia Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Insomnia Therapy Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Insomnia Therapy Market Share by Country (2015-2020)
Table 58. Merck & Co. Company Details
Table 59. Merck & Co. Business Overview
Table 60. Merck & Co. Product
Table 61. Merck & Co. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 62. Merck & Co. Recent Development
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Product
Table 66. Sanofi Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Product
Table 71. Pfizer Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Takeda Pharmaceutical Company Ltd. Company Details
Table 74. Takeda Pharmaceutical Company Ltd. Business Overview
Table 75. Takeda Pharmaceutical Company Ltd. Product
Table 76. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 77. Takeda Pharmaceutical Company Ltd. Recent Development
Table 78. Purdue Pharmaceuticals L.P. Company Details
Table 79. Purdue Pharmaceuticals L.P. Business Overview
Table 80. Purdue Pharmaceuticals L.P. Product
Table 81. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 82. Purdue Pharmaceuticals L.P. Recent Development
Table 83. Eisai, Co. Ltd. Company Details
Table 84. Eisai, Co. Ltd. Business Overview
Table 85. Eisai, Co. Ltd. Product
Table 86. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 87. Eisai, Co. Ltd. Recent Development
Table 88. Meda Consumer Healthcare Company Details
Table 89. Meda Consumer Healthcare Business Overview
Table 90. Meda Consumer Healthcare Product
Table 91. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 92. Meda Consumer Healthcare Recent Development
Table 93. Pernix Therapeutics Business Overview
Table 94. Pernix Therapeutics Product
Table 95. Pernix Therapeutics Company Details
Table 96. Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 97. Pernix Therapeutics Recent Development
Table 98. Vanda Pharmaceuticals Company Details
Table 99. Vanda Pharmaceuticals Business Overview
Table 100. Vanda Pharmaceuticals Product
Table 101. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 102. Vanda Pharmaceuticals Recent Development
Table 103. ECR Pharmaceuticals Company Details
Table 104. ECR Pharmaceuticals Business Overview
Table 105. ECR Pharmaceuticals Product
Table 106. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 107. ECR Pharmaceuticals Recent Development
Table 108. Fidia Farmaceutici Company Details
Table 109. Fidia Farmaceutici Business Overview
Table 110. Fidia Farmaceutici Product
Table 111. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 112. Fidia Farmaceutici Recent Development
Table 113. Dainippon Sumitomo Company Details
Table 114. Dainippon Sumitomo Business Overview
Table 115. Dainippon Sumitomo Product
Table 116. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 117. Dainippon Sumitomo Recent Development
Table 118. Biocodex Company Details
Table 119. Biocodex Business Overview
Table 120. Biocodex Product
Table 121. Biocodex Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 122. Biocodex Recent Development
Table 123. Eli Lilly and Company Company Details
Table 124. Eli Lilly and Company Business Overview
Table 125. Eli Lilly and Company Product
Table 126. Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 127. Eli Lilly and Company Recent Development
Table 128. Ebb Therapeutics Company Details
Table 129. Ebb Therapeutics Business Overview
Table 130. Ebb Therapeutics Product
Table 131. Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020) (US$ Million)
Table 132. Ebb Therapeutics Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Insomnia Therapy Market Share by Type: 2020 VS 2026
Figure 2. Non-pharmacological Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Global Insomnia Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Ambulatory Surgical Center Case Studies
Figure 7. Home Care Case Studies
Figure 8. Insomnia Therapy Report Years Considered
Figure 9. Global Insomnia Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Insomnia Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Insomnia Therapy Market Share by Regions (2021-2026)
Figure 12. Global Insomnia Therapy Market Share by Players in 2019
Figure 13. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2019
Figure 15. North America Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Insomnia Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 43. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 44. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 45. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 46. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 47. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 48. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 49. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 50. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 51. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 52. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 53. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 54. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 56. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed